Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Clover Announces Advance Purchase Agreement with Gavi for Over 400 Million Doses of Clover's COVID-19 Vaccine for the COVAX Facility

prnasiaJune 30, 2021

Tag: Clover , GAVI , Covax , COVID-19 vaccine

PharmaSources Customer Service